Tranter Named 2017 Research Rising Star in College of Medicine
Michael Tranter, PhD, assistant professor in the Division of Cardiovascular Health and Disease, has been chosen for the 2017 Research Rising Star Award in the College of Medicine. Tranter completed his PhD in Molecular, Cellular and Biochemical Pharmacology at the University of Cincinnati in 2010 along with a two-year postdoctoral fellowship in UCs Department of Pharmacology and Cell Biophysics. He was retained as a faculty member in the Division of Cardiovascular Health and Disease in 2012. Tranters research focuses on the mechanistic role of Human Antigen R (HuR) during the development and progression of pathological cardiac hypertrophy. Tranters work has been funded by an American Heart Association Scientist Development Grant and an NIH-NHLBI R01 to study HuR as a novel mediator of cardiac hypertrophy; an NIH-NCAI sub-award and UC Technology Commercialization Accelerator Grant to commercialize a bioassay for detecting RNA-protein binding; and numerous internal grants.
Related Stories
UC students organize free health clinic happening July 11-12
July 10, 2026
The University of Cincinnati student chapter of Remote Area Medical is holding its annual free health clinic July 11-12. The clinic is open to adults and children, with no income requirements. Anyone in the area who needs medical, dental or vision care will have a chance to get it for free, with no insurance required.
Is speech-to-text AI really reliable?
July 10, 2026
UC researcher Nelly Elsayed’s study in the International Journal of Medical Informatics reveals key risks in clinical speech-to-text AI and shows why human review is essential.
Hoxworth Blood Center CEO advocates on Capitol Hill during National Blood Advocacy Week
July 9, 2026
Hoxworth Blood Center, University of Cincinnati, has announced that David Oh, MD, director and chief executive officer, joined blood center leaders, patient advocates and partner organizations in Washington, D.C., in June as part of Blood Advocacy Week, a national initiative led by America’s Blood Centers to strengthen the nation’s blood supply.